The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites

Abstract Malaria control and elimination are threatened by the emergence and spread of resistance to artemisinin-based combination therapies (ACTs). Experimental evidence suggests that when an artemisinin (ART)-sensitive (K13 wild-type) Plasmodium falciparum strain is exposed to ART derivatives such...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: L. Dembele, X. Ang, M. Chavchich, G. M. C. Bonamy, J. J. Selva, M. Yi-Xiu Lim, C. Bodenreider, B. K. S. Yeung, F. Nosten, B. M. Russell, M. D. Edstein, J. Straimer, D. A. Fidock, T. T. Diagana, P. Bifani
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/99f7a3c6162945b384400f88d2d8584f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:99f7a3c6162945b384400f88d2d8584f
record_format dspace
spelling oai:doaj.org-article:99f7a3c6162945b384400f88d2d8584f2021-12-02T15:06:20ZThe Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites10.1038/s41598-017-02440-62045-2322https://doaj.org/article/99f7a3c6162945b384400f88d2d8584f2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-02440-6https://doaj.org/toc/2045-2322Abstract Malaria control and elimination are threatened by the emergence and spread of resistance to artemisinin-based combination therapies (ACTs). Experimental evidence suggests that when an artemisinin (ART)-sensitive (K13 wild-type) Plasmodium falciparum strain is exposed to ART derivatives such as dihydroartemisinin (DHA), a small population of the early ring-stage parasites can survive drug treatment by entering cell cycle arrest or dormancy. After drug removal, these parasites can resume growth. Dormancy has been hypothesized to be an adaptive physiological mechanism that has been linked to recrudescence of parasites after monotherapy with ART and, possibly contributes to ART resistance. Here, we evaluate the in vitro drug sensitivity profile of normally-developing P. falciparum ring stages and DHA-pretreated dormant rings (DP-rings) using a panel of antimalarial drugs, including the Plasmodium phosphatidylinositol-4-OH kinase (PI4K)-specific inhibitor KDU691. We report that while KDU691 shows no activity against rings, it is highly inhibitory against DP-rings; a drug effect opposite to that of ART. Moreover, we provide evidence that KDU691 also kills DP-rings of P. falciparum ART-resistant strains expressing mutant K13.L. DembeleX. AngM. ChavchichG. M. C. BonamyJ. J. SelvaM. Yi-Xiu LimC. BodenreiderB. K. S. YeungF. NostenB. M. RussellM. D. EdsteinJ. StraimerD. A. FidockT. T. DiaganaP. BifaniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
L. Dembele
X. Ang
M. Chavchich
G. M. C. Bonamy
J. J. Selva
M. Yi-Xiu Lim
C. Bodenreider
B. K. S. Yeung
F. Nosten
B. M. Russell
M. D. Edstein
J. Straimer
D. A. Fidock
T. T. Diagana
P. Bifani
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites
description Abstract Malaria control and elimination are threatened by the emergence and spread of resistance to artemisinin-based combination therapies (ACTs). Experimental evidence suggests that when an artemisinin (ART)-sensitive (K13 wild-type) Plasmodium falciparum strain is exposed to ART derivatives such as dihydroartemisinin (DHA), a small population of the early ring-stage parasites can survive drug treatment by entering cell cycle arrest or dormancy. After drug removal, these parasites can resume growth. Dormancy has been hypothesized to be an adaptive physiological mechanism that has been linked to recrudescence of parasites after monotherapy with ART and, possibly contributes to ART resistance. Here, we evaluate the in vitro drug sensitivity profile of normally-developing P. falciparum ring stages and DHA-pretreated dormant rings (DP-rings) using a panel of antimalarial drugs, including the Plasmodium phosphatidylinositol-4-OH kinase (PI4K)-specific inhibitor KDU691. We report that while KDU691 shows no activity against rings, it is highly inhibitory against DP-rings; a drug effect opposite to that of ART. Moreover, we provide evidence that KDU691 also kills DP-rings of P. falciparum ART-resistant strains expressing mutant K13.
format article
author L. Dembele
X. Ang
M. Chavchich
G. M. C. Bonamy
J. J. Selva
M. Yi-Xiu Lim
C. Bodenreider
B. K. S. Yeung
F. Nosten
B. M. Russell
M. D. Edstein
J. Straimer
D. A. Fidock
T. T. Diagana
P. Bifani
author_facet L. Dembele
X. Ang
M. Chavchich
G. M. C. Bonamy
J. J. Selva
M. Yi-Xiu Lim
C. Bodenreider
B. K. S. Yeung
F. Nosten
B. M. Russell
M. D. Edstein
J. Straimer
D. A. Fidock
T. T. Diagana
P. Bifani
author_sort L. Dembele
title The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites
title_short The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites
title_full The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites
title_fullStr The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites
title_full_unstemmed The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites
title_sort plasmodium pi(4)k inhibitor kdu691 selectively inhibits dihydroartemisinin-pretreated plasmodium falciparum ring-stage parasites
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/99f7a3c6162945b384400f88d2d8584f
work_keys_str_mv AT ldembele theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT xang theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT mchavchich theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT gmcbonamy theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT jjselva theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT myixiulim theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT cbodenreider theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT bksyeung theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT fnosten theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT bmrussell theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT mdedstein theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT jstraimer theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT dafidock theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT ttdiagana theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT pbifani theplasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT ldembele plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT xang plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT mchavchich plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT gmcbonamy plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT jjselva plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT myixiulim plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT cbodenreider plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT bksyeung plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT fnosten plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT bmrussell plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT mdedstein plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT jstraimer plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT dafidock plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT ttdiagana plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
AT pbifani plasmodiumpi4kinhibitorkdu691selectivelyinhibitsdihydroartemisininpretreatedplasmodiumfalciparumringstageparasites
_version_ 1718388530679382016